3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Myelodysplastic Syndromes
12
Hematologic Neoplasms
7
Lymphoma
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia
5
Graft vs Host Disease
5
Primary Myelofibrosis
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hodgkin Disease
4
Burkitt Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Interventions
Cyclophosphamide
13
Temozolomide
10
Magnetic Resonance Spectroscopy
10
dinutuximab
8
X-Rays
8
Specimen Handling
8
Irinotecan
8
Biopsy
8
Phantoms, Imaging
7
Topotecan
6
Nuclear Medicine Department, Hospital
6
fludarabine
5
Vincristine
5
3-Iodobenzylguanidine
5
fludarabine phosphate
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Etoposide
4
tipifarnib
3
sargramostim
3
Radiotherapy
3
Melphalan
3
Isotretinoin
3
Filgrastim
3
Doxorubicin
3
Carboplatin
3
ulixertinib
2
tazemetostat
2
selpercatinib
2
saponin QA-21V1
2
pembrolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Tacrolimus
×
90 days
×
Clear all
No trials found.